Format
Sort by
Items per page

Send to

Choose Destination

Best matches for ACE Inhibitors+ARBs+DCM+LVEF+LVES+NYHA Class:

Not all angiotensin-converting enzyme inhibitors are equal: focus on ramipril and perindopril. Dinicolantonio JJ et al. Postgrad Med. (2013)

Angiotensin-converting enzyme inhibitor-induced angioedema. Bezalel S et al. Am J Med. (2015)

An alternative certification examination ("ACE") in surgery. Morris MC et al. J Surg Educ. (2014)

Search results

Items: 1 to 20 of 1610

  • The following term was not found in PubMed: Inhibitors+ARBs+DCM+LVEF+LVES+NYHA.
1.
2.
3.

Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.

Teng TK, Tromp J, Tay WT, Anand I, Ouwerkerk W, Chopra V, Wander GS, Yap JJ, MacDonald MR, Xu CF, Chia YM, Shimizu W; ASIAN-HF investigators, Richards AM, Voors A, Lam CS.

Lancet Glob Health. 2018 Sep;6(9):e1008-e1018. doi: 10.1016/S2214-109X(18)30306-1.

4.

SGLT2 inhibitor dapagliflozin limits podocyte damage in proteinuric nondiabetic nephropathy.

Cassis P, Locatelli M, Cerullo D, Corna D, Buelli S, Zanchi C, Villa S, Morigi M, Remuzzi G, Benigni A, Zoja C.

JCI Insight. 2018 Aug 9;3(15). pii: 98720. doi: 10.1172/jci.insight.98720. [Epub ahead of print]

5.

[Russian Heart Failure Society, Russian Society of Cardiology. Russian Scientific Medical Society of Internal Medicine Guidelines for Heart failure: chronic (CHF) and acute decompensated (ADHF). Diagnosis, prevention and treatment].

Mareev VY, Fomin IV, Ageev FT, Begrambekova YL, Vasyuk YA, Garganeeva AA, Gendlin GE, Glezer MG, Gote SV, Dovzhenko TV, Kobalava ZD, Koziolova NA, Koroteev AV, Mareev YV, Ovchinnikov AG, Perepech NB, Tarlovskaya EI, CHesnikova AI, Shevchenko AO, Arutyunov GP, Belenkov YN, Galyavich AS, Gilyarevskiy SR, Drapkina OM, Duplyakov DV, Lopatin YM, Sitnikova MY, Skibitskiy VV, SHlyakhto EV.

Kardiologiia. 2018 SJun;(S6):1-164. Russian. No abstract available.

PMID:
30081796
6.

Effect of Anti-Hypertensive Medication History on Arteriovenous Fistula Maturation Outcomes.

Wang K, Zelnick LR, Imrey PB, deBoer IH, Himmelfarb J, Allon MD, Cheung AK, Dember LM, Roy-Chaudhury P, Vazquez MA, Kusek JW, Feldman HI, Beck GJ, Kestenbaum B; the Hemodialysis Fistula Maturation Study Group.

Am J Nephrol. 2018;48(1):56-64. doi: 10.1159/000491828. Epub 2018 Aug 2.

PMID:
30071516
7.

Neurodevelopmental toxicity in the mouse neocortex following prenatal exposure to acetamiprid.

Kagawa N, Nagao T.

J Appl Toxicol. 2018 Jul 25. doi: 10.1002/jat.3692. [Epub ahead of print]

PMID:
30047162
8.

Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry.

Greene SJ, Butler J, Albert NM, DeVore AD, Sharma PP, Duffy CI, Hill CL, McCague K, Mi X, Patterson JH, Spertus JA, Thomas L, Williams FB, Hernandez AF, Fonarow GC.

J Am Coll Cardiol. 2018 Jul 24;72(4):351-366. doi: 10.1016/j.jacc.2018.04.070.

PMID:
30025570
9.

The Effects of Neighborhood Context on Exposure to Adverse Childhood Experiences (ACE) Among Adolescents Involved in the Juvenile Justice System: Latent Classes and Contextual Effects.

Wolff KT, Cuevas C, Intravia J, Baglivio MT, Epps N.

J Youth Adolesc. 2018 Jul 2. doi: 10.1007/s10964-018-0887-5. [Epub ahead of print]

PMID:
29968064
10.

Changes in left ventricular geometry during antihypertensive treatment.

Salvetti M, Paini A, Bertacchini F, Stassaldi D, Aggiusti C, Agabiti Rosei C, Bassetti D, Agabiti-Rosei E, Muiesan ML.

Pharmacol Res. 2018 Aug;134:193-199. doi: 10.1016/j.phrs.2018.06.026. Epub 2018 Jun 26. Review.

PMID:
29959031
11.

Treatment of cyclosporine induced hypertension: Results from a long-term observational study using different antihypertensive medications.

Marienhagen K, Lehner F, Klempnauer J, Hecker H, Borlak J.

Vascul Pharmacol. 2018 Jun 19. pii: S1537-1891(17)30362-2. doi: 10.1016/j.vph.2018.06.012. [Epub ahead of print]

PMID:
29933079
12.

ACE Inhibitor-Induced Angioedema: a Review.

Kostis WJ, Shetty M, Chowdhury YS, Kostis JB.

Curr Hypertens Rep. 2018 Jun 8;20(7):55. doi: 10.1007/s11906-018-0859-x. Review.

PMID:
29884969
13.

Treatment of heart failure with preserved ejection fraction.

Monteverde A, Carlino V, Ganci G, Taormina G, Barbagallo M.

Monaldi Arch Chest Dis. 2018 Jun 7;88(2):951. doi: 10.4081/monaldi.2018.951.

14.

A comparison of various MRI feature types for characterizing whole brain anatomical differences using linear pattern recognition methods.

Monté-Rubio GC, Falcón C, Pomarol-Clotet E, Ashburner J.

Neuroimage. 2018 Sep;178:753-768. doi: 10.1016/j.neuroimage.2018.05.065. Epub 2018 Jun 2.

15.
16.

Early occurrence of drug intolerance as risk factor during follow up in patients with acute coronary syndrome or coronary revascularization.

Albani S, Fabris E, Doimo S, Barbati G, Perkan A, Merlo M, Gatti G, Di Lenarda A, Van't Hof A, Maras P, Sinagra G.

Eur Heart J Cardiovasc Pharmacother. 2018 May 29. doi: 10.1093/ehjcvp/pvy017. [Epub ahead of print]

PMID:
29846559
17.

The repercussion of stopping reimbursement of olmésartan on antihypertensive drugs prescription and blood pressure control of treated hypertensive patients in France.

Dufay A, Gallo A, Hanon O, Vaïsse B, Girerd X.

Ann Cardiol Angeiol (Paris). 2018 Jun;67(3):149-153. doi: 10.1016/j.ancard.2018.04.024. Epub 2018 May 26.

PMID:
29807620
18.
19.

Simultaneous determination of nine neonicotinoids in human urine using isotope-dilution ultra-performance liquid chromatography-tandem mass spectrometry.

Zhang Q, Wang X, Li Z, Jin H, Lu Z, Yu C, Huang YF, Zhao M.

Environ Pollut. 2018 Sep;240:647-652. doi: 10.1016/j.envpol.2018.04.144. Epub 2018 May 15.

PMID:
29772515
20.

Long-term effects of patiromer for hyperkalaemia treatment in patients with mild heart failure and diabetic nephropathy on angiotensin-converting enzymes/angiotensin receptor blockers: results from AMETHYST-DN.

Pitt B, Bakris GL, Weir MR, Freeman MW, Lainscak M, Mayo MR, Garza D, Zawadzki R, Berman L, Bushinsky DA.

ESC Heart Fail. 2018 Aug;5(4):592-602. doi: 10.1002/ehf2.12292. Epub 2018 May 16.

Supplemental Content

Loading ...
Support Center